1. Home
  2. BDL vs IPSC Comparison

BDL vs IPSC Comparison

Compare BDL & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flanigan's Enterprises Inc.

BDL

Flanigan's Enterprises Inc.

HOLD

Current Price

$30.23

Market Cap

53.2M

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

58.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDL
IPSC
Founded
1959
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
58.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BDL
IPSC
Price
$30.23
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.00
AVG Volume (30 Days)
1.9K
1.5M
Earning Date
02-10-2026
11-13-2025
Dividend Yield
1.83%
N/A
EPS Growth
49.97
N/A
EPS
2.71
N/A
Revenue
$206,084,000.00
$113,337,000.00
Revenue This Year
N/A
$1,590.09
Revenue Next Year
N/A
N/A
P/E Ratio
$10.95
N/A
Revenue Growth
9.56
4122.69
52 Week Low
$22.61
$0.34
52 Week High
$35.98
$1.19

Technical Indicators

Market Signals
Indicator
BDL
IPSC
Relative Strength Index (RSI) 55.11 61.52
Support Level $29.14 $0.91
Resistance Level $31.89 $1.05
Average True Range (ATR) 1.14 0.12
MACD 0.18 0.01
Stochastic Oscillator 74.36 66.72

Price Performance

Historical Comparison
BDL
IPSC

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: